[Clinical evaluation of anti-rheumatic drugs: experimentation by ordeal?]. (Record no. 4553909)

MARC details
000 -LEADER
fixed length control field 00823 a2200265 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250512113217.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 197605s 0 0 ita d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0048-7449
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Grennan, D M
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 19760520
245 00 - TITLE STATEMENT
Title [Clinical evaluation of anti-rheumatic drugs: experimentation by ordeal?].
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Reumatismo
Date of publication, distribution, etc.
300 ## - PHYSICAL DESCRIPTION
Extent 47-67 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: English Abstract; Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Anti-Inflammatory Agents
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Human Experimentation
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Rheumatic Diseases
General subdivision drug therapy
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Canesi, B
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lee, P
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ahola, S J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Buchanan, W W
773 0# - HOST ITEM ENTRY
Title Reumatismo
Related parts vol. 26
-- no. 1
-- p. 47-67

No items available.